Your browser doesn't support javascript.
loading
Toxicity Profiling and Antihyperuricemic Activity of Goubion: A Polyherbal Formulation.
Sadia, Halima; Naveed, Safila; Rehman, Hina; Usman, Rafia; Qamar, Fatima; Yasmeen, Sidra; Sana, Aisha; Mughal, Mahrukh; Asif, Saima; Razzaq, Ghulam.
Afiliación
  • Sadia H; Department of Pharmacy Practice, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
  • Naveed S; Department of Pharmacy Practice, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
  • Rehman H; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
  • Usman R; Department of Pharmacy Practice, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan.
  • Qamar F; Department of Chemical Engineering, NED University, Karachi, Pakistan.
  • Yasmeen S; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
  • Sana A; Central Drug Laboratory, Drug Regulatory Authority of Pakistan, Karachi, Pakistan.
  • Mughal M; Department of Pharmaceutics, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
  • Asif S; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
  • Razzaq G; Central Drug Laboratory, Drug Regulatory Authority of Pakistan, Karachi, Pakistan.
Article en En | MEDLINE | ID: mdl-36846052
ABSTRACT
The objective of the present study was to determine the acute and subacute toxicity profile of a polyherbal formulation called "Goubion" in addition to the in vivo antihyperuricemic study using fructose-induced hyperuricemia. Goubion is a combination of Colchicum autumnale (tuber), Tribulus terresteris (fruit), Vitex negundo (leaves), Smilax chinensis (root), Glycyrrhiza glabra (root), and Curcuma amada (rhizome). The acute toxicity study revealed no signs of mortality and morbidity at a single dose of 2000 mg/kg. Similarly, the results of the subacute repeated dose toxicity study exhibited no signs of mortality at any of the doses. However, significant changes in hematological, biochemical, and renal parameters were recorded at the dose of 60 mg/kg. Antihyperuricemic activity was tested at the dose of 15 mg/kg and 20 mg/kg of Goubion, respectively against 5 mg/kg Allopurinol. Based on the antihyperuricemic study, we infer that the Goubion has a significant hypouricemic action, as it remarkably decreased the elevated uric acid levels. The results also suggest the potential inhibitory capability of Goubion on xanthine oxidase dehydrogenase might be the mechanism behind the hypouricemic effect.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Evid Based Complement Alternat Med Año: 2023 Tipo del documento: Article País de afiliación: Pakistán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Evid Based Complement Alternat Med Año: 2023 Tipo del documento: Article País de afiliación: Pakistán
...